“The longer one listens to a patient, often that’s where the solutions arise.”
A sleep medicine and neurophysiology specialist, Dr. Reploeg is the medical director of the Samaritan Sleep Medicine Program, which is supported by the providers at The Corvallis Clinic’s Sleep Medicine Department.
Dr. Reploeg treats a variety of sleep disorders for both adults and children, such as obstructive sleep apnea, narcolepsy, and restless leg syndrome.
Language(s) - English
Dr. Reploeg (pronounced Rep-Loag) first listens to the patient and tries not to jump to conclusions. “After we have an understanding of what we want to improve with respect to their sleep disorder,” he said, “we then work as a team.”
Originally wanting to be a neuroscientist, Dr. Reploeg realized he wanted more direct involvement in improving people’s lives. “There’s a lot of value in doing research,” he said, “but I enjoy helping people day to day. That’s where my interest in science merged into an interest in medicine and being able to work directly with patients.”
Dr. Reploeg especially enjoys practicing sleep medicine because he can help people usually without medications, employing physical or behavioral treatments. “And people get better from these conditions fairly quickly,” he said. “That’s a very satisfying part of what I do, because we can see improvements sometimes overnight.”
Dr. Reploeg, a Minnesota native, and his wife were attracted to the Pacific Northwest because of its climate and beauty. “Specifically, we were looking for a small town to raise our family,” he said. “We also enjoy having close proximity to the ocean and to mountains. Outdoor activities are how we spend our free time, such as skiing in the winter and biking and tennis in the summer. We have all those opportunities in the mid-valley.”
Sleep Medicine and Clinical Neurophysiology, Washington University in St. Louis, MO, 2005
Neurology, Washington University, St. Louis, MO, 2004
Washington University, St. Louis, MO, 2000
American Board of Psychiatry and Neurology, American Board of Clinical Neurophysiology, and American Board of Sleep Medicine
2006: RLL103660/RLL103663; “A Double-Blind, Placebo-Controlled, Cross-Over Polysomnography Study of Ropinirole XR in Restless Legs Syndrome (RLS) Patients With Periodic Limb Movements (PLMS) in Sleep”; GlaxoSmithKline
2005: Clinical Investigator Training, The Corvallis Clinic, P.C.
2005: “The Arousal Threshold and Neurocognitive Effects of Sodium Oxybate”
Abstracts and Presentations
2006: Mark D Reploeg; “Restless Legs Syndrome: Epidemiology, Pathophysiology, and Treatment Options”, Good Samaritan Grand Rounds
2006: Mark D Reploeg; “Restless Legs Syndrome: Epidemiology, Pathophysiology, and Treatment Options”, Albany General Grand Rounds
2006: Mark D Reploeg; “Insomnia: Mechanisms of Sleep/Wake Regulation and Theraputic Options”, OHSU Medical School, First Annual Charles R. Drew, MD lectureship
2005: Mark D. Reploeg, Eric Powell, Jennifer Svoboda, Rachel Weels and Stephen Duntley; “The arousal threshold and neurocognitive effects of sodium oxybate”, APSS 19th Annual Meeting, Abstract/poster presentation
2001: Mark D. Reploeg and Joel A. Goebel; “Migraine Associated Dizziness”; American Neurotology Society meeting platform presentation
2001: Mark D. Reploeg, Paul T. Akins, Jin-Moo Lee; “Iron-deficiency anemia, thrombocytosis and stroke: A case series and review of the literature”; ANA 126th Annual Meeting, Abstract/poster presentation
2000: Mark D. Reploeg, Gregory A. Storch, David B. Clifford; “BK virus in central nervous system disease”; ANA 125th Annual Meeting, Abstract/poster presentation
2000: Katie D. Vo, Mark D. Reploeg, Dan K. Kido, Chung Y. Hsu, Benjamin Littenberg; “Agreement among “expert” readers in interpreting CT scans of acute ischemic stroke patients”; AUR Annual Meeting, Abstract presentation
1997: Mark D. Reploeg and Paul C. Bridgman; “The role of myosis IIB in nerve cell growth cones”; Washington University Summer Research Symposium, poster presentation
1995: Mark D. Reploeg and M.A. Tutus; “Dissection of the in vivo function of class I Myosins”; Duke University Howard Hughes Student Research Fellowship Symposium, poster presentation
2002: Mark D. Reploeg and Joel A. Goebel; “Migraine-associated vertigo: Patient characteristics and management options”; Otology and Neurotology 2002; 23:364-71
2001: Mark D. Reploeg, Gregory A. Storch and David B. Clifford; “BK Virus: A clinical review”; Clinical Infectious Diseases 2001; 33:191-202
2000: Justin S. Wu, Shubada N. Ahya, Mark D. Reploeg, Gary G. Singer, Daniel C Brennan, Todd K. Howard, Jeffrey A. Lowell; “Pheochromocytoma presenting as a giant cystic tumor of the liver”; Surgery 2000; 128:482-4
The Patient Rating score is an average of all responses to care provider related questions on the Patient Satisfaction Survey.
About Survey Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments From Patients
you can tell Dr.Reploag is passionate about his profession and patients.
It has been a while since an appointment went this well and professionally by everyone.
Dr R. So great with his patience.
It was better than I expected as it was the first time this way. All in all it went very well. I wouldn’t hesitate to do it again.
Very caring and very knowledgeable.
Click on the appropriate link below to enter your provider’s telemedicine waiting room for your scheduled appointment.